CSIMarket
 

Novanta Inc   (NASDAQ: NOVT)

Novanta Inc 's

Competitiveness




 

NOVT Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Novanta Inc reported Revenue increase in the 1 quarter 2026 by 10.38 % year on year.
The revenue growth was below Novanta Inc 's competitors' average revenue growth of 10.91 %, achieved in the same quarter.

List of NOVT Competitors

With a net margin of 8.19 % Novanta Inc achieved higher profitability than its competitors.

More on NOVT Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Novanta Inc Net Income in the 1 quarter 2026 fell year on year by -0.51%, while most of its competitors have experienced a contraction in net income by -1.74 %.

<<  NOVT Stock Performance Comparisons


Novanta Inc 's Comment on Competition and Industry Peers


The company operates in a competitive environment across various markets, applications, and technologies. Its competitors range from large domestic and foreign companies offering comprehensive goods and services to smaller organizations specializing in limited, highly specialized products or services. The industry is characterized by rapidly evolving technology and changing customer demands, necessitating continuous investment. Key factors for success include technological advancements, product performance, price-for-performance ratios, throughput performance, total cost of ownership, product quality, application knowledge, reputation, customer service, speed to market, geographical presence, and customer relationships.



  

Overall company Market Share Q1 2026

Overall company revenue, increased less, than total company revenues, at 10.38 % and lost market share.
<<  More on NOVT Market Share.
 
*Market share is calculated based on total revenue.

  News about Novanta Inc Contracts

BEDFORD, Mass. Novanta Inc. (Nasdaq NOVT) is set to make significant waves at Bairds upcoming 2024 Gl...

August 6, 2024
Novanta Inc. Showcases Resilience at Baird’s 2024 Global Healthcare Conference Amid Mixed Quarter Results BEDFORD, Mass. Novanta Inc. (Nasdaq: NOVT) is set to make significant waves at Baird s upcoming 2024 Global Healthcare Conference, scheduled for September 10, 2024, in New York City. Matthijs Glastra, the company s Chair and Chief Executive Officer, will represent Novanta as it continues to establish itself as a key technology partner for medical and advanced technology equipment manufacturers.As a leading global supplier of core technology solutions, Novanta plays a pivotal role in supporting both medical and advanced industrial original equipment manufacturers. The company’s latest financial re...





Publicly Traded Peers of Novanta Inc




Nn Inc
Share Performance



-5.67%
Over The Past 5 Days



Nn Inc
Profile

NN Inc is an industrial company that operates through three business segments: Power Solutions, Mobile Solutions, and Life Sciences. The company's business model involves providing engineering and manufacturing solutions for complex engineering problems, offering diversified products and services across various industries, and focusing on innovation and customer-centricity to drive growth and sustainability in their operations.

More about Nn Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 165.508 mill. $ 434.971 mill. $ -15.235 mill.

Sources: Novanta Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Novanta Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.